1-(1-Methyl-1H-pyrazol-5-yl)ethanone

Catalog No.: 
ACRNAI270
CAS No.: 
137890-05-2
Molecular Formula: 
C6H8N2O
Molecular Weight: 
124.14
1-(1-Methyl-1H-pyrazol-5-yl)ethanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$75.00InquiryInquiry
1g98%$102.00InquiryInquiry
5g98%$358.00InquiryInquiry
10g98%$613.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(1-Methyl-1H-pyrazol-5-yl)ethanone
IUPAC Name1-(1-methyl-1H-pyrazol-5-yl)ethan-1-one
MDL No.MFCD04968784
Molecular FormulaC6H8N2O
Molecular Weight124.14
SMILESCN1N=CC=C1C(C)=O
InChI KeyUXNMMULCZUAIHE-UHFFFAOYSA-N
Synonym1-(1-methyl-1H-pyrazol-5-yl)ethanone | 137890-05-2 | 5-acetyl-1-methylpyrazole | 1-(2-methylpyrazol-3-yl)ethanone | Ethanone, 1-(1-methyl-1H-pyrazol-5-yl)- | 1-(2-Methyl-2H-pyrazol-3-yl)ethanone | MFCD04968784 | 1-(1-methyl-1h-pyrazol-5-yl)ethan-1-one | Ethanone, 1-(1-me
CAS No.137890-05-2
PubChem CID7017416

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACRNAI270 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRNAI270 route product structure diagram
    ACRNAI270137890-05-2
Inquiry

2. ACRNAI270 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRNAI270 route product structure diagram
    ACRNAI270137890-05-2
Inquiry

3. ACRNAI270 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRNAI270 route product structure diagram
    ACRNAI270137890-05-2
Inquiry

Comments (0)